- Feb 6, 2010
- 6,247
- 1,967
TSLA has killed me these last 2 months smh
Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
Low risk since it’s so cheap. Tencent has a stake so it may turn it into something like whatsapp? Idk. Scared money don’t make no money
I hear you...there are much better companies to put your investment behind imo tho, especially in the tech sector.
Snap is a kinda trash product. At best, it flops around like TWTR's price did for years or it could continue as a playground for bears and see it's price hit single digits.
I don't see a path for profitability for them in the next couple quarters.
Good luck tho.
I'm looking to buy in. Just waiting for the right price.TSLA has killed me these last 2 months smh
Any suggestions on what to invest in the tech sector? Have a couple grand to play around with. Have some invested in AMD but want to diversify more.
You should look at NVDA. They are doing much better than AMD. Of course, it’s more expensive, but AMD really can’t compete with them.
They'll get there. They were a product of their own hype for a while, but the cynics and bears are getting a hold of it now. I'm hoping to see a solid drop in stock price before buying more, because even at $300 I think their current price is expensive looking at the short term opportunities.SNAP is far from cheap given they lost $400M last quarter.
I like the idea of investing in Musk but TSLA is so overvalued I won't touch it again until they prove they can do the basic stuff they say they'll do.
wish i got in on SQ as well, but i did ok with PYPL
Yo why you think that? It dropped from 250 to 15 ? What’s so special about it rising soon?Ticker Symbol VRX.
You guys will thank me later. 1-2 years. ✌
Yo why you think that? It dropped from 250 to 15 ? What’s so special about it rising soon?
Valeant is a carcass that all hedge funds invested in 2013-2015. The company tanked in <1 year.
Company is over-levered (peep the interest expenses vs. revenue), is dealing with the Allergan settlement, and can't divest any of its businesses for less than carrying value.
A lot of bad stuff mixed with some good. It has no other way to go but up, but who knows?